TELO – telomir pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Telomir Pharmaceuticals Reports Telomir-1 Outperforms FDA-Approved Gold-Standard Iron Chelator Deferoxamine (DFO) in Reducing Intracellular Iron in a Human Cell Line [Yahoo! Finance]
Telomir Pharmaceuticals (NASDAQ:TELO) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Form PRER14A Telomir Pharmaceuticals,
Form 8-K Telomir Pharmaceuticals, For: Nov 24
Form 8-K Telomir Pharmaceuticals, For: Nov 14
Form PREM14A Telomir Pharmaceuticals, For: Nov 20
Form 8-K Telomir Pharmaceuticals, For: Nov 20
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.